Objectives: Modern fat grafting breast augmentation allows to successfully enhance a breast. However, there is no fine control on breast footprint and IMF, as well as on breast projection and shape. In this paper, the author introduces a novel scarless technique to enhance breast shape in fat grafting breast augmentation (FGBA) and evaluate its beneficial effect in improving the cosmetic outcomes.
Introduction: When compared to breast augmentation with implants, FGBA is a closed procedure based on “liquid” augmentation, which does not allow to provide a high defined volume as for “solid” (i.e. implant) augmentation where the implant dictates shapes, volume and volume distribution. Thus, FGBA suffers three main technical limitations: no fine control on final breast footprint, no fine control on position of the new inframammary fold (IMF) and no fine control on breast projection and shape.
Materials / method: Fifty-one consecutive patients undergoing cosmetic breast augmentation with fat only between September 2012 and August 2016 were retrospectively reviewed. In the first 29 cases(56%) we did not use dual anchor cog threads(Group A-control group) whereas in the remaining 22 cases(44%), we used dual anchor cog threads (Group B, case group).Breast shape analysis was performed using a standardized evaluation method and the BREAST-Q was used to study patients' satisfaction. Mann-Whitney U test and Chi-square tests were for categorical variables, independent-samples t-test for continuous variables.
Results: No significative difference in graft take was found (mean Group-A 71.2% vs Group-B 71.6%, p<0.05). Group B showed significantly higher rating than Group A, for lower pole profile, IMF and lateral footprint definition. No major postoperative complications were experienced in both groups. In Group B no thread-related complications were experienced.
Conclusion: The dual anchor thread suture is a novel, effective, simple, reliable, safe and scarless method to improve breast shape in fat grafting breast augmentation, allowing to achieve high-defined results.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
是
请注明名称(个人,公司,学会等等): WOW Medical, Korea.
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
是
请注明日期: Pending
和审阅情况: January 2019
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。